UNICA IRIS Institutional Research Information System

ZUDDAS, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 103.990
NA - Nord America 9.063
AS - Asia 2.976
SA - Sud America 552
AF - Africa 47
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 3
Totale 116.660
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 100.218
US - Stati Uniti d'America 8.931
CN - Cina 1.258
SG - Singapore 1.131
NL - Olanda 1.128
UA - Ucraina 749
SE - Svezia 534
BR - Brasile 491
GB - Regno Unito 358
DE - Germania 312
FR - Francia 245
FI - Finlandia 209
VN - Vietnam 148
HK - Hong Kong 112
CA - Canada 75
KR - Corea 74
IN - India 66
RU - Federazione Russa 44
AT - Austria 29
AU - Australia 28
TR - Turchia 28
MX - Messico 25
ES - Italia 24
AR - Argentina 22
BD - Bangladesh 22
ZA - Sudafrica 20
CH - Svizzera 19
BE - Belgio 17
PL - Polonia 17
EC - Ecuador 15
IQ - Iraq 15
IL - Israele 13
SA - Arabia Saudita 13
DK - Danimarca 12
ID - Indonesia 12
AE - Emirati Arabi Uniti 11
IR - Iran 11
MA - Marocco 11
NO - Norvegia 10
RO - Romania 10
CR - Costa Rica 9
JP - Giappone 9
PK - Pakistan 9
GR - Grecia 8
JO - Giordania 8
UZ - Uzbekistan 8
IE - Irlanda 7
LT - Lituania 7
DO - Repubblica Dominicana 6
HN - Honduras 6
PT - Portogallo 6
VE - Venezuela 6
CO - Colombia 5
BA - Bosnia-Erzegovina 4
CZ - Repubblica Ceca 4
KZ - Kazakistan 4
MY - Malesia 4
PH - Filippine 4
TW - Taiwan 4
AL - Albania 3
AZ - Azerbaigian 3
BO - Bolivia 3
CL - Cile 3
EE - Estonia 3
EG - Egitto 3
EU - Europa 3
GT - Guatemala 3
JM - Giamaica 3
PY - Paraguay 3
TN - Tunisia 3
ET - Etiopia 2
KE - Kenya 2
MD - Moldavia 2
MT - Malta 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
SI - Slovenia 2
SM - San Marino 2
UY - Uruguay 2
AO - Angola 1
BH - Bahrain 1
BZ - Belize 1
DZ - Algeria 1
GD - Grenada 1
GE - Georgia 1
GI - Gibilterra 1
IS - Islanda 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MU - Mauritius 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
RS - Serbia 1
Totale 116.658
Salva come PNG Salva come JPEG
Città #
Cagliari 92.347
Uta 5.293
Amsterdam 1.063
Fairfield 921
Woodbridge 846
Ashburn 671
Chandler 596
Houston 573
Boardman 563
Singapore 459
Ann Arbor 444
Dallas 413
Jacksonville 390
Wilmington 384
Seattle 357
Nyköping 340
Cambridge 293
Beijing 260
Milan 242
Rome 226
Boston 155
Hefei 146
Los Angeles 139
Nanjing 121
Dearborn 112
Santa Clara 98
Hong Kong 90
Helsinki 83
Dong Ket 80
Buffalo 74
Shanghai 69
Seoul 63
San Diego 61
New York 53
Redwood City 53
Padova 49
Shenyang 46
Charleston 44
Guangzhou 39
São Paulo 39
Nanchang 38
Turin 36
Bari 35
Verona 35
The Dalles 34
Nuremberg 31
Toronto 31
London 30
Ho Chi Minh City 29
Palermo 29
Sassari 29
Changsha 28
Hebei 27
Jiaxing 26
Redondo Beach 26
Florence 25
Naples 25
Norwalk 25
Washington 25
Munich 24
Frankfurt am Main 23
Bologna 21
Council Bluffs 21
Tianjin 21
Orange 20
Stockholm 20
Atlanta 19
Jinan 19
Zhengzhou 19
Chicago 18
Pune 18
Brooklyn 17
Auburn Hills 16
Hanoi 16
Ningbo 16
Genoa 14
Johannesburg 14
San Francisco 14
Warsaw 14
Brescia 13
Catania 13
Perugia 13
Columbus 12
Falls Church 12
Messina 12
Parma 12
Phoenix 12
Rio de Janeiro 12
Sydney 12
Torino 12
Brussels 11
Manchester 11
Montreal 11
Mountain View 11
Saint Petersburg 11
Denver 10
Hangzhou 10
Mexico City 10
Quito 10
Redmond 10
Totale 109.463
Salva come PNG Salva come JPEG
Nome #
Child and Adolescent Behavior Inventory (CABI): Standardization for age 6-17 years and first clinical application 2.013
Prospective observational study protocol to investigate long-term adverse effects of methylphenidate in children and adolescents with ADHD: The Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study 1.840
Systematic review of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit/hyperactivity disorder 1.814
Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate 1.669
Practitioner Review: Current best practice in the use of parent training and other behavioural interventions in the treatment of children and adolescents with attention deficit hyperactivity disorder 1.588
Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine 1.583
Neurological and psychiatric adverse effects of long-term methylphenidate treatment in ADHD: A map of the current evidence 1.555
Reports of Perceived Adverse Events of Stimulant Medication on Cognition, Motivation, and Mood: Qualitative Investigation and the Generation of Items for the Medication and Cognition Rating Scale 1.533
Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis 1.485
Cognitive training for attention-deficit/hyperactivity disorder: Meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials 1.474
Supplementation with polyunsaturated fatty acids (PUFAs) in the management of attention deficit hyperactivity disorder (ADHD) 1.451
Unmet needs in paediatric psychopharmacology: Present scenario and future perspectives 1.436
Development and psychometric properties of the Suicidality: Treatment Occurring in Paediatrics (STOP) Suicidality Assessment Scale (STOP-SAS) in children and adolescents 1.428
The Italian autism network (ITAN): A resource for molecular genetics and biomarker investigations 1.378
Effects of methylphenidate on height in ADHD children. The monitoring of bone age within the ADDUCE project 1.329
Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe 1.329
The control of responsiveness in ADHD by catecholamines: evidence for dopaminergic, noradrenergic and interactive roles 1.284
Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder 1.266
Corrigendum: Child and adolescent behavior inventory (CABI): A new instrument for epidemiological studies and pre-clinical evaluation 1.255
Effects of long-term methylphenidate use on growth and blood pressure: Results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS) 1.228
ADHD and hyperkinetic disorder 1.220
ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group 1.209
Re-thinking treatment targets in child and adolescent psychiatry 1.177
null 1.154
Pediatric acute-onset neuropsychiatric syndrome: A data mining approach to a very specific constellation of clinical variables 1.096
Psychosocial risk factors for suicidality in children and adolescents 1.046
null 1.045
Methylphenidate long-term effects on psychiatric outcomes in a Sardinian ADHD population: preliminary results from the prospective ADDUCE project 983
null 980
1H-NMR-Based Metabolomics in Autism Spectrum Disorder and Pediatric Acute-Onset Neuropsychiatric Syndrome 961
CRS-R. Conners’ Rating Scales. Revised. Manuale 960
A neurodevelopment approach for a transitional model of early onset schizophrenia 931
Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies 877
Artificial neural networks analysis of polysomnographic and clinical features in pediatric acute-onset neuropsychiatric syndrome (Pans): From sleep alteration to “brain fog” 864
Systematic Review and Meta-analysis: Screening Tools for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents 794
Erratum to: Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: A systematic review of head-to-head studies[ BMC Psychiatry. (2013)13, 237] 785
Metabolomic Characterization of Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS) 782
null 754
Prevalence and correlates of mental disorders among adolescents in Italy: The PrISMA Study 751
null 750
Identifying Neurobiological Markers in Obsessive–Compulsive Disorder: A Study Protocol for a Cross-Sectional Study in Subgroups of Differing Phenotype 739
Efficacy of lisdexamfetamine dimesylate throughout the day in children and adolescents with attention-deficit/hyperactivity disorder: results from a randomized, controlled trial 730
null 699
Unbalanced risk-benefit analysis of ADHD drugs – Authors' reply 699
null 689
Profili cognitivi e disturbi psicopatologici. Evidenze neurobiologiche, diagnosi, trattamento 687
null 675
null 665
null 658
The management of ADHD in children and adolescents: bringing evidence to the clinic: perspective from the European ADHD Guidelines Group (EAGG) 646
Neuropsychological characterization of aggressive behavior in children and adolescents with cd/odd and effects of single doses of medications: The protocol of the matrics_wp6-1 study 645
Long term methylphenidate exposure and growth in children and adolescents with ADHD. A systematic review and meta-analysis 641
Omega-3/6 supplementation for mild to moderate inattentive ADHD: a randomised, double-blind, placebo-controlled efficacy study in Italian children 637
null 632
The pharmacological treatment of aggression in children and adolescents with conduct disorder. Do callous-unemotional traits modulate the efficacy of medication? 622
Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis 612
The poor outcome of conduct disorders: a need for innovative, more effective therapeutic interventions 605
null 603
null 595
Vortioxetine for Major Depressive Disorder in Adolescents: 12-Week Randomized, Placebo-Controlled, Fluoxetine-Referenced, Fixed-Dose Study 590
null 588
Increased Response-Time Variability Across Different Cognitive Tasks in Children With ADHD 582
null 581
null 581
null 568
Post hoc analyses of the impact of previous medication on the efficacy of lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder in a randomized, controlled trial 566
null 564
null 549
Eziologia 548
Clinical characteristics, neuroimaging findings, and neuropsychological functioning in attention-deficit hyperactivity disorder: Sex differences 546
null 536
A crucial role for basic emotion awareness in the development of emotion regulation? 536
Methylphenidate effects on height and bone age in ADHD children. 24 month follow up within the prospective ADDUCE project 536
Association of Risk of Suicide Attempts With Methylphenidate Treatment 528
The neuropsychological characterization of aggressive behaviour in children and adolescents with CD/ODD: preliminary results from a multicentric case-control study (MATRICS_consortium) 521
null 519
null 517
null 506
I Disturbi depressivi in età evolutiva 503
null 501
null 501
null 497
Management and treatment of attention-deficit/hyperactivity disorder 496
Use of atomoxetine in patients with attention-deficit hyperactivity disorder and comorbid conditions 496
A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents 495
null 491
Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder: randomized-withdrawal study design 484
The MTA at 8 480
null 477
EFFICACY STUDY OF AN OMEGA-3/6 COMBINATION FOR MILD- TO MODERATE-INATTENTIVE ADHD: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL IN ITALIAN CHILDREN 476
null 467
Non-pharmacological interventions for Attention-Deficit/Hyperactivity Disorder: Systematic review and meta-analyses of randomised controlled trials of dietary and psychological treatments 460
European clinical guidelines for hyperkinetic disorder - first upgrade 459
The quality of life of children with attention deficit/hyperactivity disorder: a systematic review 458
Plasma poly-unsatured fatty acids profile in children with inattentive ADHD - preliminary results of an efficacy Italian study with omega 3/6 448
null 444
SRS Social Responsiveness Scale di John N. Constantino e Christian P. Grube 435
null 428
Paediatric European Risperidone Studies (PERS): context, rationale, objectives, strategy, and challenges. 415
Health-related quality of life and functional outcomes from a randomized-withdrawal study of long-term lisdexamfetamine dimesylate treatment in children and adolescents with attention-deficit/hyperactivity disorder 410
Totale 82.319
Salva come PNG Salva come JPEG
Categoria #
all - tutte 171.808
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 171.808
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110.784 0 0 0 0 3.262 1.867 1.869 953 511 590 483 1.249
2021/20227.717 573 518 324 892 763 432 371 602 813 872 740 817
2022/202314.499 1.096 1.876 1.615 1.101 1.067 1.151 670 1.949 962 856 1.497 659
2023/202416.961 829 681 632 1.058 1.953 2.626 2.791 1.014 844 1.224 1.784 1.525
2024/202533.367 5.755 8.871 5.369 4.342 2.223 1.915 1.670 232 420 1.380 581 609
2025/20262.903 678 333 998 776 118 0 0 0 0 0 0 0
Totale 117.158